empagliflozin glp-1 New Guidelines for Type 2 Diabetes in 2025 Glucagon-like peptide-1 receptor: mechanisms and

Why Meal Prep Is Non-Negotiable on GLP-1 Medications GLP-1 receptor agonists like semaglutide and tirzepatide work by slowing gastric emptying and signaling your brain that youre full

Important changes include: (1) the decision to treat high-risk individuals with a glucagon-like-peptide 1 (GLP-1) receptor agonist or sodiumglucose cotransporter 2 (SGLT2) inhibitor to reduce major adverse cardiovascular events (MACE), hospitalisation for heart failure (hHF), cardiovascular death or chronic kidney disease (CKD) progression should be considered independently of baseline HbA1c or individualised HbA1c target

There is still a lot we dont know about the potential side effects of drugs used for weight loss.

Two announcements this week, on opposite ends of healthcare: Queue raised money to build autonomous robotic pharmacies

Learn more about weight loss injections offered at our Baton Rouge weight loss clinic